Erythropoietin
- Level
- Commodity
- Parent
- 51131500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131506This classification denotes a chemotherapy regimen used to treat non-hodgkins lymphoma with the molecular formula C809H1301N229O240S5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64FS3BFH5W, more generally known as erythropoietin. European Medicines Agency schedules erythropoietin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06575MIG. The term ERYTHROPOIETIN is an International Non-Proprietary Name or INN. As of Q4 2014, ERYTHROPOIETIN remains the US FDA Preferred Term for this commodity. Erythropoietin bears US NLM identifiers UMLS ID C0014822 and NCI Concept Code C20429. SMILES: NONE.
Same parent
Under 51131500 · 16Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.